NeuroBo Pharmaceuticals
in glucose control when administered with other therapies gra | NeuroBo Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
December 2023
Slide
10 of 25
Related slides by other companies
Alkermes
Investor Conference
January 2022
receptor agonist | Alkermes
Avenue Therapeutics
IPO
October 2022
is a selective receptor agonist that produces and activity receptor | Avenue Therapeutics
Bionomics
Investor Presentation
April 2022
mechanistic validation of as evidenced by response observed reduction in response due to negative modulation of the receptors blood brain barrier penetration and nicotinic receptor target engagement in humans be | Bionomics
Kymera
Investor Day
December 2021
is a key initiator of type and type inflammation of mucosal tissues via and family receptors | Kymera
Other recent decks by NeuroBo Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Securities Offering
October 2022
Investor Presentation
March 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io